As previously reported, BofA upgraded Molina Healthcare (MOH) to Buy from Underperform with a price target of $250, up from $152, due to Medicaid margins likely bottoming in 2026. The return to target margins is “more a matter of time and math” as state data slowly catches up to trend/risk pool shifts in 2024/25, improving rates and margins in 2027, the analyst tells investors.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare upgraded to Buy from Underperform at BofA
- Molina Healthcare price target raised to $180 from $145 at Truist
- Molina Healthcare price target raised to $163 from $144 at TD Cowen
- Molina Healthcare price target raised to $159 from $141 at Wells Fargo
- Molina Healthcare price target raised to $129 from $109 at Deutsche Bank